Cargando…

NK Cell Plasticity in Cancer

Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sizhe, Dhar, Payal, Wu, Jennifer D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780970/
https://www.ncbi.nlm.nih.gov/pubmed/31546818
http://dx.doi.org/10.3390/jcm8091492
_version_ 1783457267735068672
author Liu, Sizhe
Dhar, Payal
Wu, Jennifer D.
author_facet Liu, Sizhe
Dhar, Payal
Wu, Jennifer D.
author_sort Liu, Sizhe
collection PubMed
description Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest that tumors could induce functional alterations in NK cells, polarizing them to tumor-promoting phenotypes. The potential functional plasticity of NK cells in the context of tumors could lead to undesirable outcomes of NK-cell based therapies. In this review, we will summarize to-date evidence of tumor-associated NK cell plasticity and provide our insights for future investigations and therapy development.
format Online
Article
Text
id pubmed-6780970
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67809702019-10-30 NK Cell Plasticity in Cancer Liu, Sizhe Dhar, Payal Wu, Jennifer D. J Clin Med Review Natural killer (NK) cells are critical immune components in controlling tumor growth and dissemination. Given their innate capacity to eliminate tumor cells without prior sensitization, NK-based therapies for cancer are actively pursued pre-clinically and clinically. However, recent data suggest that tumors could induce functional alterations in NK cells, polarizing them to tumor-promoting phenotypes. The potential functional plasticity of NK cells in the context of tumors could lead to undesirable outcomes of NK-cell based therapies. In this review, we will summarize to-date evidence of tumor-associated NK cell plasticity and provide our insights for future investigations and therapy development. MDPI 2019-09-19 /pmc/articles/PMC6780970/ /pubmed/31546818 http://dx.doi.org/10.3390/jcm8091492 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Liu, Sizhe
Dhar, Payal
Wu, Jennifer D.
NK Cell Plasticity in Cancer
title NK Cell Plasticity in Cancer
title_full NK Cell Plasticity in Cancer
title_fullStr NK Cell Plasticity in Cancer
title_full_unstemmed NK Cell Plasticity in Cancer
title_short NK Cell Plasticity in Cancer
title_sort nk cell plasticity in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780970/
https://www.ncbi.nlm.nih.gov/pubmed/31546818
http://dx.doi.org/10.3390/jcm8091492
work_keys_str_mv AT liusizhe nkcellplasticityincancer
AT dharpayal nkcellplasticityincancer
AT wujenniferd nkcellplasticityincancer